期刊文献+

正常血压的原发性高血压患者子女Catestatin水平变化及临床意义

下载PDF
导出
摘要 目的探讨正常血压的原发性高血压患者子女血浆(Catestatin)水平的变化及其临床意义。方法分为正常血压的原发性高血压子女组和健康对照组,测定两组血浆Catestatin、尿儿茶酚胺。结果与对照组比较,正常血压的原发性高血压患者子女组血浆Catestatin水平下降(P<0.01),尿儿茶酚胺水平升高(P<0.01)。结论正常血压的原发性高血压患者子女血浆Catestatin水平的降低先于其血压的升高,提示Catestatin在原发性高血压的发生、发展过程起重要作用。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第18期4396-4397,共2页 Chinese Journal of Gerontology
基金 河北省卫生厅科研课题(No.20110617)
  • 相关文献

参考文献6

  • 1Simon JP, Bader MF, Aunnis D. Secretion from chromaffin cells is con- trolled by chromogranin A-derived peptides[ J]. Proc Nat Acad Sei USA, 1988 ;85 (5) : 1712-6.
  • 2Mahata SK, O' Connor DT, Mahata M, et al. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist[ J]. J Clin Invest, 1997; 100(6) :1623-33.
  • 3Mahata SK, Mahata M, Wakade AR, et al. Primary structure and function of the eateeholamine release inhibitory peptide eatestatin chromogrannin A ( 344-364 ) : identification of amino acid residues crucial for activity [ J]. Mol Endocrinol,2000 ; 14(10) : 1525-35.
  • 4Mahapatra NR, O'Connor DT, Vaingankar SM, et al. Hypertension from targeted ablation of chromogrannin A can be rescued by the human or- tholog[ J]. J Clin Invest ,2005 ; 115 (7) : 1942-52.
  • 5O'Connor DT, Kailasam MT, Kennedy BP, et al. Early decline in the cate- cholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension [ J ].J Hypertens, 2002 ; 20 ( 7 ) : 1335-45.
  • 6Salem RM, Cadman PE, Chen Y, et al. Chromogranin a polymorphisms are associated with hypertensive renal disease [ J ]. J Am Soc Nephrol, 2008 ; 19 ( 3 ) :600-14.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部